Table 1.
Genotype Testing Among HIV-Positive Prisoners in the North Carolina Department of Corrections, October 2006–February 2010
| |
Study population (N=1911) |
Population with genotype (N=367) |
|
||
|---|---|---|---|---|---|
| N | % | N | % | p value | |
| Sex | |||||
| Female | 305 | 16.0 | 52 | 14.2 | 0.30 |
| Male | 1606 | 315 | |||
| Race | |||||
| Black | 1527 | 79.9 | 291 | 79.3 | 0.74 |
| Nonblack | 384 | 76 | |||
| Incarceration | |||||
| First incarcerationa | 494 | 25.9 | 93 | 25.3 | 0.97 |
| Reincarceration | 1296 | 67.8 | 251 | 68.4 | |
| Otherb | 121 | 23 | |||
| ARV treatment in prison | |||||
| Ever | 1445 | 75.6 | 329 | 89.6 | <0.0001 |
| Never | 466 | 38 | |||
a
First incarceration during study period.
b
Other includes safekeeper, returned from parole, or awaiting sentencing.
ARV, antiretroviral.